Cargando…
Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase
The bovine viral diarrhea virus (BVDV), a pestivirus from the family of Flaviviridae is ubiquitous and causes a range of clinical manifestations in livestock, mainly cattle. Two quinolinecarboxamide analogues were identified in a CPE-based screening effort, as selective inhibitors of the in vitro bo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144022/ https://www.ncbi.nlm.nih.gov/pubmed/32178258 http://dx.doi.org/10.3390/molecules25061283 |
_version_ | 1783519751465598976 |
---|---|
author | Musiu, Simone Castillo, Yunierkis Perez Muigg, Alexandra Pürstinger, Gerhard Leyssen, Pieter Froeyen, Mathy Neyts, Johan Paeshuyse, Jan |
author_facet | Musiu, Simone Castillo, Yunierkis Perez Muigg, Alexandra Pürstinger, Gerhard Leyssen, Pieter Froeyen, Mathy Neyts, Johan Paeshuyse, Jan |
author_sort | Musiu, Simone |
collection | PubMed |
description | The bovine viral diarrhea virus (BVDV), a pestivirus from the family of Flaviviridae is ubiquitous and causes a range of clinical manifestations in livestock, mainly cattle. Two quinolinecarboxamide analogues were identified in a CPE-based screening effort, as selective inhibitors of the in vitro bovine viral diarrhea virus (BVDV) replication, i.e., TO505-6180/CSFCI (average EC(50) = 0.07 µM, SD = 0.02 µM, CC(50) > 100 µM) and TO502-2403/CSFCII (average EC(50) = 0.2 µM, SD = 0.06 µM, CC(50) > 100 µM). The initial antiviral activity observed for both hits against BVDV was corroborated by measuring the inhibitory effect on viral RNA synthesis and the production of infectious virus. Modification of the substituents on the quinolinecarboxamide scaffold resulted in analogues that proved about 7-fold more potent (average EC(50) = 0.03 with a SD = 0.01 µM) and that were devoid of cellular toxicity, for the concentration range tested (SI = 3333). CSFCII resistant BVDV variants were selected and were found to carry the F224P mutation in the viral RNA-dependent RNA polymerase (RdRp), whereas CSFCI resistant BVDV carried two mutations in the same region of the RdRp, i.e., N264D and F224Y. Likewise, molecular modeling revealed that F224P/Y and N264D are located in a small cavity near the fingertip domain of the pestivirus polymerase. CSFC-resistant BVDV proved to be cross-resistant to earlier reported pestivirus inhibitors (BPIP, AG110, LZ37, and BBP) that are known to target the same region of the RdRp. CSFC analogues did not inhibit the in vitro activity of recombinant BVDV RdRp but inhibited the activity of BVDV replication complexes (RCs). CSFC analogues likely interact with the fingertip of the pestivirus RdRp at the same position as BPIP, AG110, LZ37, and BBP. This indicates that this region is a “hot spot” for the inhibition of pestivirus replication. |
format | Online Article Text |
id | pubmed-7144022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71440222020-04-13 Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase Musiu, Simone Castillo, Yunierkis Perez Muigg, Alexandra Pürstinger, Gerhard Leyssen, Pieter Froeyen, Mathy Neyts, Johan Paeshuyse, Jan Molecules Article The bovine viral diarrhea virus (BVDV), a pestivirus from the family of Flaviviridae is ubiquitous and causes a range of clinical manifestations in livestock, mainly cattle. Two quinolinecarboxamide analogues were identified in a CPE-based screening effort, as selective inhibitors of the in vitro bovine viral diarrhea virus (BVDV) replication, i.e., TO505-6180/CSFCI (average EC(50) = 0.07 µM, SD = 0.02 µM, CC(50) > 100 µM) and TO502-2403/CSFCII (average EC(50) = 0.2 µM, SD = 0.06 µM, CC(50) > 100 µM). The initial antiviral activity observed for both hits against BVDV was corroborated by measuring the inhibitory effect on viral RNA synthesis and the production of infectious virus. Modification of the substituents on the quinolinecarboxamide scaffold resulted in analogues that proved about 7-fold more potent (average EC(50) = 0.03 with a SD = 0.01 µM) and that were devoid of cellular toxicity, for the concentration range tested (SI = 3333). CSFCII resistant BVDV variants were selected and were found to carry the F224P mutation in the viral RNA-dependent RNA polymerase (RdRp), whereas CSFCI resistant BVDV carried two mutations in the same region of the RdRp, i.e., N264D and F224Y. Likewise, molecular modeling revealed that F224P/Y and N264D are located in a small cavity near the fingertip domain of the pestivirus polymerase. CSFC-resistant BVDV proved to be cross-resistant to earlier reported pestivirus inhibitors (BPIP, AG110, LZ37, and BBP) that are known to target the same region of the RdRp. CSFC analogues did not inhibit the in vitro activity of recombinant BVDV RdRp but inhibited the activity of BVDV replication complexes (RCs). CSFC analogues likely interact with the fingertip of the pestivirus RdRp at the same position as BPIP, AG110, LZ37, and BBP. This indicates that this region is a “hot spot” for the inhibition of pestivirus replication. MDPI 2020-03-12 /pmc/articles/PMC7144022/ /pubmed/32178258 http://dx.doi.org/10.3390/molecules25061283 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Musiu, Simone Castillo, Yunierkis Perez Muigg, Alexandra Pürstinger, Gerhard Leyssen, Pieter Froeyen, Mathy Neyts, Johan Paeshuyse, Jan Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase |
title | Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase |
title_full | Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase |
title_fullStr | Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase |
title_full_unstemmed | Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase |
title_short | Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase |
title_sort | quinolinecarboxamides inhibit the replication of the bovine viral diarrhea virus by targeting a hot spot for the inhibition of pestivirus replication in the rna-dependent rna polymerase |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144022/ https://www.ncbi.nlm.nih.gov/pubmed/32178258 http://dx.doi.org/10.3390/molecules25061283 |
work_keys_str_mv | AT musiusimone quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase AT castilloyunierkisperez quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase AT muiggalexandra quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase AT purstingergerhard quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase AT leyssenpieter quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase AT froeyenmathy quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase AT neytsjohan quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase AT paeshuysejan quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase |